A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.
The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions.
The default principle—that someone is free to do what he or she desires in the absence of a compelling reason why he or she should not—may make it possible to resolve ethical disputes without recourse to a particular moral framework.
AMA J Ethics. 2015;17(4):289-296. doi:
10.1001/journalofethics.2015.17.4.spec1-1504.
Despite the natural desire in obstetrics for a happy outcome, sometimes the common aggressive interventions will not help maintain a pregnancy until viability.